Aspen Aerogels (ASPN) Invested Capital (2013 - 2026)

Aspen Aerogels has reported Invested Capital for 14 years, with the latest figure at $274.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 33.03% year-over-year to $274.7 million; the trailing twelve-month figure through Mar 2026 stood at $274.7 million (down 33.03% YoY), and the FY2025 full-year result was $301.0 million, down 57.59% from the prior year.
• Invested Capital for Q1 2026 stood at $274.7 million, down from $301.0 million in the prior quarter.
• The five-year high for Invested Capital was $709.7 million in Q4 2024, with the low at $164.8 million in Q2 2022.
• Historically, Invested Capital has averaged $399.7 million across 5 years, with a median of $410.2 million in 2025.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 248.45% — and 2025, when it plunged 57.59%.
• Aspen Aerogels' Invested Capital stood at $447.4 million in 2022, then climbed by 9.08% to $488.1 million in 2023, then soared by 45.41% to $709.7 million in 2024, then sank by 57.59% to $301.0 million in 2025, then retreated by 8.72% to $274.7 million in 2026.
• The last three Invested Capital figures came in at $274.7 million (Q1 2026), $301.0 million (Q4 2025), and $375.8 million (Q3 2025), per Business Quant data.